The Young Investigator Operating (YIO) grant program is intended to promote creativity in all domains of arthritis-related research. The Young Investigator Operating Grants are intended to promote creativity in all domains of research and are therefore not restricted to the strategic themes. If a CIHR grant is awarded in the same year, The Society’s successful applicant is expected to accept the CIHR grant. The Society will however award the applicant $25,000 to assist with laboratory start up expenses.
Applicants will be required to submit a Letter of Intent (LOI) prior to being invited to submit a full application. Applications (both letter of intent and full application) will be judged by a panel of peers that include members of SAC and arthritis consumers. If the applicant receives a CIHR grant in the same year (October 2017-September 2018), the applicant is expected to accept the CIHR grant and turn down the TAS award. Pending available funds, The Society aims to support a maximum of three (3) projects
- A Young investigator is defined by The Society as an individual who is within 4 years of their first academic appointment and has never previously held an operating grant of more than $70,000 from the Society, CAN, CIHR, NSERC or other funding agencies.
- The Young Investigator is expected to perform the roles and responsibilities of a Nominated Principal Investigator.
- Awards will have clear expectations for protected time for research activities, for research productivity, for participation in Strategic Networking Workshops, and participation in The Society’s Research Scholar webinar series.
- Performance will be monitored annually by The Society.
- Expectations are high scholarly activity, and end of‐grant reporting (including 2 years reporting after the end of grant) is expected to fully capture the results of the activities of these grants. Expectations include annual reporting, attendance at Strategic Networking Workshops, presentations in the Scholars webinar series, and acknowledgement of The Society in all research communications.